Diverse clonal fates emerge upon drug treatment of homogeneous cancer cells-Reference-Cited by-同舟云学术

Diverse clonal fates emerge upon drug treatment of homogeneous cancer cells

Published:2023-07-19 Issue:7974 Volume:620 Page:651-659
ISSN:0028-0836
Container-title:Nature
language:en
Short-container-title:Nature

Author:

Goyal Yogesh^ORCID,Busch Gianna T.^ORCID,Pillai Maalavika^ORCID,Li Jingxin,Boe Ryan H.,Grody Emanuelle I.,Chelvanambi Manoj^ORCID,Dardani Ian P.^ORCID,Emert Benjamin,Bodkin Nicholas^ORCID,Braun Jonas,Fingerman Dylan,Kaur Amanpreet,Jain Naveen,Ravindran Pavithran T.,Mellis Ian A.,Kiani Karun,Alicea Gretchen M.,Fane Mitchell E.^ORCID,Ahmed Syeda Subia^ORCID,Li Haiyin,Chen Yeqing,Chai Cedric^ORCID,Kaster Jessica,Witt Russell G.,Lazcano Rossana,Ingram Davis R.,Johnson Sarah B.^ORCID,Wani Khalida,Dunagin Margaret C.^ORCID,Lazar Alexander J.,Weeraratna Ashani T.,Wargo Jennifer A.^ORCID,Herlyn Meenhard^ORCID,Raj Arjun^ORCID

Publisher

Springer Science and Business Media LLC

Subject

Multidisciplinary

Link

https://www.nature.com/articles/s41586-023-06342-8.pdf

Reference67 articles.

1. Shaffer, S. M. et al. Rare cell variability and drug-induced reprogramming as a mode of cancer drug resistance. Nature 546, 431–435 (2017).

2. Rambow, F. et al. Toward minimal residual disease-directed therapy in melanoma. Cell 174, 843–855.e19 (2018).

3. Schuh, L. et al. Gene networks with transcriptional bursting recapitulate rare transient coordinated high expression states in cancer. Cell Syst. 10, 363–378.e12 (2020).

4. Roesch, A. et al. A temporarily distinct subpopulation of slow-cycling melanoma cells is required for continuous tumor growth. Cell 141, 583–594 (2010).

5. Sharma, S. V. et al. A chromatin-mediated reversible drug-tolerant state in cancer cell subpopulations. Cell 141, 69–80 (2010).

Cited by 71 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Folylpolyglutamate synthetase inactivation in relapsed ALL induces a druggable folate metabolic vulnerability;Drug Resistance Updates;2024-11

2. Cancer drug-tolerant persister cells: from biological questions to clinical opportunities;Nature Reviews Cancer;2024-09-02

3. Cancer plasticity in therapy resistance: Mechanisms and novel strategies;Drug Resistance Updates;2024-09

4. Population Diversity at the Single-Cell Level;Annual Review of Genomics and Human Genetics;2024-08-27

5. Targeting Interferon-Driven Inflammatory Memory Prevents Epigenetic Evolution of Cancer Immunotherapy Resistance;2024-08-16